Association of apoptosis with the inhibition of extracellular signal- regulated protein kinase activity in the tumor necrosis factor α-resistant ovarian carcinoma cell line UCl 101

Molecular Carcinogenesis

Volumn 25, Issue 1, 1999, Pages 14-20

  Yazlovitskaya, Eugenia M ^a   Pelling, Jill C ^a   Persons, Diane L ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; C jun N terminal 1; Ovarian cancer; PD 98059

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

TRIXIS;

EID: 0032957128     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199905)25:1<14::AID-MC2>3.0.CO;2-V     Document Type: Article

References (34)

1. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM. Recombinant human necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 1985;230:943-945.
2. Wu S, Rodabaugh K, Martinez-Maza O, et al. Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α. Am J Obstet Gynecol 1992;166:997-1007.
3. Wu S, Boyer R, Whitaker A, et al. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res 1993;53:1939-1944.
4. Spriggs DR, Imamura K, Rodriguez C, Sariban E, Kufe DW. Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest 1988;81:455-460.
5. Sancho-Tello M, Marcinkiewicz JL, Justice WM, Kimler BF, Terranova PE, Hunter VJ. Reduction of human necrosis factor-α bioactivity by a human ovarian epithelial cancer cell line in vitro. Am J Obstet Gynecol 1995;173:1470-1476.
6. Minden A, Lin A, McMahon M, et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994;266:1719-1723.
7. Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 1994;269:26396-26401.
8. Geng Y, Valbracht J, Lotz M. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 1996;98:2425-2430.
9. Modur V, Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell inflammatory responses to tumor necrosis factor-α. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem 1996;271:13094-13102.
10. Shievella AR, Chen JH, Graham JR, Lin LL MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 1997;272:12069-12075.
11. Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996;381:800-803.
12. Pena LA, Fuks Z, Kolesnik R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997;53:615-621.
13. Eastman A. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin Cancer Biol 1995;6:45-52.
14. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-735.
15. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996;8:205-215.
16. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996;74:589-607.
17. Anderson P. Kinase cascades regulating entry into apoptosis. Microbiology and Molecular Biology Reviews 1997;Mar:33-46.
18. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vivo and in vitro by TNF-alpha requires transcriptional arrest. J Immunol 1994; 153:1778-1788.
19. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1330.
20. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNFα-induced cell death. Science 1996;274:782-784.
21. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNFα-induced apoptosis by NF-κB. Science 1996;274:787-789.
22. Wang C-Y, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 1996;274:784-787.
23. Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275:90-94.
24. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997;275:200-203.
25. ueous one solution cell proliferation assay. Promega Notes 1996;59:19-23.
26. Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J Biol Chem 1991;266:15266-15276.
27. Dhanwada KR, Dickens M, Neades R, Davis R, Felling JC. Differential effects of UV-B and UV-C components of solar radiation on MAP kinase signal transduction pathways in epidermal keratinocytes. Oncogene 1995;11:1947-1953.
28. Hermann M, Lorenz H-M, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for isolation of apoptotic DNA fragments. Nucleic Acids Res 1994;22:5506-5507.
29. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-7689.
30. Servant MJ, Giasson E, Meloche S. Inhibition of growth-factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 1996;271:16047-16052.
31. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
32. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 1994;4:694-701.
33. Marshall CJ. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
34. MAP kinase in adult rat hepatocytes. FEBS Lett 1997;412:9-14.